510(k) Report

510(k) · Cleared

Recalled · Class II · 2016

Xpert Mrsa

K070462510(k) TraditionalCleared Apr 17, 200760-day reviewClass II21 CFR 866.1640Recalls 1

Data to Oct 25, 2026 (FDA decisions) Oct 12, 2026 (recalls) Sep 30, 2026 (MAUDE) refreshed weekly, last Nov 3, 2026

Cepheid · NQX System, Nucleic Acid Amplification Test, Dna, Methicillin Resistant Staphylococcus Aureus, Direct Specimen

Cleared on Apr 17, 2007 as substantially equivalent to K033415 (Infectio Diagnostic (I.D.I.), Inc., 2004) after a 60-day review. Its family tree reaches back 2 generations to 1985. 10 later devices descend from it. It has been recalled once.

Decided
Apr 17, 2007
Review
60 days
Class
Class II
Product code
NQX
Recalls
1
Predicates
1

Its longest line of descent runs back 2 generations to K850291 (1985). 3 ancestors in all. 10 later devices descend from it, 2 citing it directly.

Other ancestors, by year clearedDescendants, by year cleared 2002: 1 other ancestor2009: 1 descendant cleared2008: 1 descendant cleared2024: 1 descendant cleared2012: 2 descendants cleared2013: 3 descendants cleared2016: 1 descendant cleared2019: 1 descendant clearedK850291 · Mueller Hinton Agar W/4% Nacl W/Antibiotics · Remel Co. · 1985 · recalledK033415 · Idi-Mrsa · Infectio Diagnostic (I.D.I.), Inc. · 2004 · recalled1990200020102020
Other ancestors, by generationDescendants, by generation 2 generations back: 1 other ancestor 1 generation forward: 2 descendants2 generations forward: 3 descendants3 generations forward: 3 descendants4 generations forward: 2 descendants K033415 · Idi-Mrsa · Infectio Diagnostic (I.D.I.), Inc. · 2004 · recalledK850291 · Mueller Hinton Agar W/4% Nacl W/Antibiotics · Remel Co. · 1985 · recalled0
  1. Root · 2 generations backK850291 Mueller Hinton Agar W/4% Nacl W/AntibioticsRemel Co. · 1985 · Recalled
  2. 1 generation backK033415 Idi-MrsaInfectio Diagnostic (I.D.I.), Inc. · 2004 · Recalled
  3. This deviceK070462 Xpert MrsaCepheid · 2007
  4. Descendant · cites it directly · 7 of its ownK093346 BD Geneohm Mrsa Acp AssayBd Diagnostics (Geneohm Sciences, Inc.) · 2009 · Recalled
  5. Descendant · 2 generations on · 4 of its ownK120138 BD Max Mrsa Assay, BD Max InstrumentBd Diagnostics (Geneohm Sciences Canada, Inc) · 2012 · Recalled
  6. Descendant · 3 generations on · 2 of its ownK133605 BD Max Mrsa XT, BD Max InstrumentGeneohm Sciences Canada, Inc. · 2013 · Recalled
  7. Descendant · 2 generations on · 1 of its ownK112937 Mrsa/SA Elite MGBElitech · 2012
  8. Descendant · cites it directly · 1 of its ownK080837 Xpert Mrsa/SA Ssti AssayCepheid · 2008

Showing 5 of 10 descendants. See all descendants

Descendants cleared per year

2008: 12009: 12012: 22013: 32016: 12019: 12024: 1
2008high 3 (2013) · low 0 (2010)2026

Most influential descendants

Showing 5 of 10 · See all
  • K093346BD Geneohm Mrsa Acp AssayBd Diagnostics (Geneohm Sciences, Inc.) · 2009 · cites it directly7descendants
  • K120138BD Max Mrsa Assay, BD Max InstrumentBd Diagnostics (Geneohm Sciences Canada, Inc) · 2012 · 2 generations on4descendants
  • K133605BD Max Mrsa XT, BD Max InstrumentGeneohm Sciences Canada, Inc. · 2013 · 3 generations on2descendants
  • K112937Mrsa/SA Elite MGBElitech · 2012 · 2 generations on1descendant
  • K080837Xpert Mrsa/SA Ssti AssayCepheid · 2008 · cites it directly1descendant
View FIG. 1 as a table

Line of descent and top descendants

GenerationNumberDeviceApplicantDecidedRecalls
−2K850291Mueller Hinton Agar W/4% Nacl W/AntibioticsRemel Co.19852
−1K033415Idi-MrsaInfectio Diagnostic (I.D.I.), Inc.20041
0 (this device)K070462Xpert MrsaCepheid2007—
+1K093346BD Geneohm Mrsa Acp AssayBd Diagnostics (Geneohm Sciences, Inc.)20092
+2K120138BD Max Mrsa Assay, BD Max InstrumentBd Diagnostics (Geneohm Sciences Canada, Inc)20124
+3K133605BD Max Mrsa XT, BD Max InstrumentGeneohm Sciences Canada, Inc.20131
+2K112937Mrsa/SA Elite MGBElitech2012—
+1K080837Xpert Mrsa/SA Ssti AssayCepheid2008—

Other ancestors by year cleared

Year clearedDevicesWith a Class I recall
200210

Descendants by year cleared

Year clearedDevicesWith a Class I recall
200810
200910
201220
201330
201610
201910
202410
FIG. 1 — Lineage of K070462, 1985–2024Source: FDA 510(k) summaries, read by 510(k) Report · How lineage is built

Get the monthly Device Review Tracker

Notable FDA decisions, review times and new Class I recalls. See an issue.

Sources: FDA 510(k) database (decision fields), the FDA summary (predicates and indications), FDA recall and enforcement reports, and MAUDE; processed by 510(k) Report. Verify on FDA.gov · Methodology and accuracy.

Planning a device in NQX? A 510(k) Report weighs predicate choices, recall history and review times for a new device like this one.

Top candidate predicates for a new NQX device

  1. #1 K243625 Xpert MRSA/SA SSTIscore 9.4 · 4 generations · no Class I recall
  2. #2 Held for the reportin the report
Get a 510(k) Report

What was it cleared against? (1)

Devices the submitter claimed this one is substantially equivalent to (*), and reference devices cited for a specific test or feature (†), as written in the FDA summary.

TypeNumberDeviceApplicantDecidedRecalls
*K033415Idi-Mrsa
Summary page 1
…Classification Microbiology Advisory Committee: Panel: 83 Predicate Device: IDI-MRSA TM Assay [5 10(k) nos. K033415/K042357] Device Description: The Cepheid Xpert methicillin-resistant Staphylococcus aureus (MRSA) Assay is a rapid, automated DN…
Infectio Diagnostic (I.D.I.), Inc.20041

Also cleared against K033415: 2 other devices →

What descends from it? (10)

2 later devices cite it directly; ranked here by how many devices descend from each in turn.

NumberDeviceApplicantDecidedDescendants
K093346BD Geneohm Mrsa Acp AssayBd Diagnostics (Geneohm Sciences, Inc.)20097
K080837Xpert Mrsa/SA Ssti AssayCepheid20081

Has anything in its family been recalled? (0 Class I)

Recalls of this device

DateClassRecallRoot causeReason
Jul 18, 2016Class IIZ-2548-2016Nonconforming Material/ComponentInternal investigation found the certain lots of MRSA kits have the potential for performance issues at lower positive sample concentrations.

No ancestor or descendant has a Class I recall.

What does this lineage say?

  • The line of descent spans 22 years and passes through 3 companies; a new generation was cleared every 18.9 years on median.
  • 2 of the 3 ancestors have a recall of any class.
  • Of its descendants, K093346 (Bd Diagnostics (Geneohm Sciences, Inc.), 2009) has gone furthest, with 7 descendants of its own.
  • 2 other devices also cite its predicate K033415.

How does its category compare?

All NQX devices

NQX System, Nucleic Acid Amplification Test, Dna, Methicillin Resistant Staphylococcus Aureus, Direct Specimen: FDA decisions, review times, recalls and adverse event reports over 20 years. 2007, this device’s year, is highlighted.

FDA decisions per year · NQX

2in 2024

2007: 22008: 22009: 12010: 32011: 22012: 22013: 42014: 12016: 12019: 22024: 2
2007high 4 (2013) · low 0 (2015)2026

2026 to Oct 25, outlined.

Median 510(k) review, days · NQX

75in 2013

2010: 70 days median2013: 75 days median
2007high 75 (2013) · low 70 (2010)2026

Receipt to decision; years with fewer than 3 clearances left blank.

Recalls per year · NQX

1in 2025

2008: 32010: 12011: 62025: 1
2007high 6 (2011) · low 0 (2007)2026

Class I (0 since 2007) Class II/III not classified

Adverse event reports per year · NQX

15in 2025

2010: 12012: 12015: 32017: 12018: 22021: 32022: 52023: 122024: 82025: 15
2007high 15 (2025) · low 0 (2007)2025

MAUDE reports naming product code NQX, not matched to any one device; reports are not rates.

View these four charts as a table
YearDecisionsMedian 510(k) review, daysRecalls (Class I)MAUDE reports
20072—00
20082—30
20091—00
201037011
20112—60
20122—01
201347500
20141—00
20150—03
20161—00
20170—01
20180—02
20192—00
20200—00
20210—03
20220—05
20230—012
20242—08
20250—115
20260—0—

What is it indicated for?

The Cepheid Xpert MRSA Assay performed on the GeneXpert® Dx System (Xpert MRSA) is a qualitative in vitro diagnostic test designed for rapid detection of methicillin-resistant Staphylococcus aureus (MRSA) from nasal swabs in patients at risk for nasal colonization. The test utilizes automated real-time polymerase chain reaction (PCR) to detect MRSA DNA. The Xpert MRSA Assay is intended to aid in the prevention and control of MRSA infections in healthcare…

Read the full statement (106 words)

The Cepheid Xpert MRSA Assay performed on the GeneXpert® Dx System (Xpert MRSA) is a qualitative in vitro diagnostic test designed for rapid detection of methicillin-resistant Staphylococcus aureus (MRSA) from nasal swabs in patients at risk for nasal colonization. The test utilizes automated real-time polymerase chain reaction (PCR) to detect MRSA DNA. The Xpert MRSA Assay is intended to aid in the prevention and control of MRSA infections in healthcare settings. The Xpert MRSA Assay is not intended to diagnose MRSA nor to guide or monitor treatment for MRSA infections. Concomitant cultures are necessary only to recover organisms for epidemiological typing or for further susceptibility testing.

Indications for use as stated in the FDA summary.

Cite this page

510(k) Report. “K070462: Xpert Mrsa.” Lineage record from FDA 510(k) data and the FDA summary. Updated Nov 3, 2026. Accessed Nov 6, 2026. https://510kreport.com/device/K070462

Report an extraction error

Tell us what is wrong; we check it against the FDA summary.

Are you the manufacturer?

Send a correction or an update to this page, for example a newer model or a public statement about a recall.

Record history
  • FDA decision record loaded May 2, 2026
  • Summary read Oct 13, 2026 (extraction version 9eaa42aa01ed)
  • Lineage and recalls computed Nov 3, 2026
  • Page last updated Nov 3, 2026